AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29311155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfatal stroke
Number of subjects: 14671
Study 29311155 — intervention group
Group type: EXPERIMENTAL
Intervention: hHF
Number of subjects: 14671
Study 27095003 — intervention group
Group type: EXPERIMENTAL
Intervention: Human α1-antitrypsin (A1AT) 240 mg/kg
Number of subjects: 10
Study 27095003 — intervention group
Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 10
Study 23846354 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 0
Study 23846354 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab variant (lacking FcR binding)
Number of subjects: 0
Study 22170862 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal endoscopic tracheal occlusion (FETO)
Number of subjects: 41
Study 22170862 — intervention group
Group type: COMPARATOR
Intervention: Standard postnatal management (Control)
Number of subjects: 41
Study 19786415 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram during intravenous interferon-alpha therapy
Number of subjects: 0
Study 19786415 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate during intravenous interferon-alpha therapy
Number of subjects: 0
Study 19786415 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram and methylphenidate together during subcutaneous interferon therapy
Number of subjects: 0
Study 19786415 — intervention group
Group type: COMPARATOR
Intervention: Alternate agent alone during subcutaneous interferon therapy
Number of subjects: 0
Study 17514589 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (submaximal exercise on bicycle ergometer, increasing work loads of 1.5, 2.0 and 2.5 W/kg, total duration 20 min)
Number of subjects: 0
Study 17514589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia (sauna at 80 degrees C for 30 min)
Number of subjects: 0
Study 17514589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (induced by insulin 0.1 IU/kg intravenously)
Number of subjects: 0
Study 17514589 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (0.75 mg subcutaneously)
Number of subjects: 0
Study 17514589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (after previous treatment with apomorphine)
Number of subjects: 0
Study 15646604 — intervention group
Group type: EXPERIMENTAL
Intervention: Caulk IRM (Dentsply Caulk, Milford, Del.) (Group I, n = 38)
Number of subjects: 73
Study 15646604 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM base with glass ionomer core (Fuji IX GP, GC America, Alsip, Ill.) (Group II, n = 35)
Number of subjects: 73
Study 15646604 — intervention group
Group type: EXPERIMENTAL
Intervention: Caulk IRM (Group I)
Number of subjects: 73
Study 15646604 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM base with glass ionomer core (Group II)
Number of subjects: 73
Study 11454118 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program on geriatrics
Number of subjects: 203
Study 11454118 — intervention group
Group type: COMPARATOR
Intervention: Comparison group of nonintervention students
Number of subjects: 203
Study 9744216 — intervention group
Group type: EXPERIMENTAL
Intervention: Training staff in a protocol for identification and acute management of abused women
Number of subjects: 8051
Study 9744216 — intervention group
Group type: COMPARATOR
Intervention: Comparison site (no intervention)
Number of subjects: 8051
Study 8092114 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam, dexamethasone, and promethazine
Number of subjects: 99
Study 8092114 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and promethazine
Number of subjects: 99
Study 3054343 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal papaverine
Number of subjects: 30
Study 3054343 — intervention group
Group type: COMPARATOR
Intervention: Conventional techniques
Number of subjects: 30
Study 31651251 — intervention group
Group type: EXPERIMENTAL
Intervention: Partnering with Parents practice support system (10-week intervention)
Number of subjects: 420
Study 31651251 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 420
Study 28097625 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention providing tailored and personalized risk information
Number of subjects: 0
Study 28097625 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention control group
Number of subjects: 0
Study 26596360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT) prior to third molar surgery
Number of subjects: 268
Study 26596360 — intervention group
Group type: COMPARATOR
Intervention: Panoramic radiography (PR)
Number of subjects: 268
Study 26596360 — intervention group
Group type: EXPERIMENTAL
Intervention: CBCT
Number of subjects: 268
Study 26596360 — intervention group
Group type: COMPARATOR
Intervention: PR
Number of subjects: 268
Study 23768675 — intervention group
Group type: EXPERIMENTAL
Intervention: telehealth-PST
Number of subjects: 121
Study 21480374 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 10
Study 21480374 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 10
Study 19348328 — intervention group
Group type: EXPERIMENTAL
Intervention: Curosurf administration
Number of subjects: 0
Study 16957969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (ID) injection of 99mTc-sulfur colloid
Number of subjects: 400
Study 16957969 — intervention group
Group type: COMPARATOR
Intervention: Intraparenchymal (IP) injection of 99mTc-sulfur colloid
Number of subjects: 400
Study 16957969 — intervention group
Group type: COMPARATOR
Intervention: Subareolar (SA) injection of 99mTc-sulfur colloid
Number of subjects: 400
Study 12818977 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the magnitude of lateral table tilt
Number of subjects: 0
Study 12818977 — intervention group
Group type: COMPARATOR
Intervention: Extremes of lateral table tilt
Number of subjects: 0
Study 10831163 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.125 IU/kg/wk for 4 weeks, then 0.25 IU/kg/wk for 6 months)
Number of subjects: 13
Study 10831163 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 13
Study 10831163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8633697 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 39
Study 8633697 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 39
Study 1638179 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulphate supplementation in 15 patients with compensated cirrhosis
Number of subjects: 60
Study 1638179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1638179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients (all groups)
Number of subjects: 60
Study 1638179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 60
Study 6368753 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of diazepam 20 mg
Number of subjects: 0
Study 6368753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of diazepam 20 mg
Number of subjects: 0
Study 6368753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30885262 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial blood gas analysis (ABG)
Number of subjects: 310
Study 30885262 — intervention group
Group type: COMPARATOR
Intervention: Standard care (noABG)
Number of subjects: 310
Study 30367238 — intervention group
Group type: EXPERIMENTAL
Intervention: Purse-string approximation (PSA)
Number of subjects: 159
Study 30367238 — intervention group
Group type: COMPARATOR
Intervention: Primary closure with a drain (PCD)
Number of subjects: 159
Study 28499930 — intervention group
Group type: EXPERIMENTAL
Intervention: High working memory capacity with low attentional bias to food cues
Number of subjects: 96
Study 28499930 — intervention group
Group type: EXPERIMENTAL
Intervention: Low working memory capacity with high attentional bias to food cues
Number of subjects: 96
Study 28499930 — intervention group
Group type: EXPERIMENTAL
Intervention: High working memory capacity with maintained attention to food cues
Number of subjects: 96
Study 28499930 — intervention group
Group type: EXPERIMENTAL
Intervention: Low working memory capacity with maintained attention to food cues
Number of subjects: 96
Study 25427598 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg IV)
Number of subjects: 45
Study 25427598 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental (4 mg/kg IV)
Number of subjects: 45
Study 25427598 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (2 mg/kg IV)
Number of subjects: 45
Study 24227734 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses to body effectors (e.g., hands, feet, limbs) in lateral occipitotemporal cortex (LOTC) and parietal cortex.
Number of subjects: 0
Study 24227734 — intervention group
Group type: COMPARATOR
Intervention: Hand-selective region in left LOTC responding to object effectors.
Number of subjects: 0
Study 24227734 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain representational similarity analysis.
Number of subjects: 0
Study 21848497 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose transdermal estradiol (E2) gel (0.9 g/day, containing E2 0.54 mg/day)
Number of subjects: 209
Study 21848497 — intervention group
Group type: COMPARATOR
Intervention: E2-free placebo
Number of subjects: 209
Study 19214559 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention
Number of subjects: 121
Study 19214559 — intervention group
Group type: COMPARATOR
Intervention: Treatment-related factors
Number of subjects: 121
Study 19214559 — intervention group
Group type: COMPARATOR
Intervention: Socio-economic and demographic characteristics
Number of subjects: 121
Study 17166576 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaphor explanation
Number of subjects: 20
Study 17166576 — intervention group
Group type: COMPARATOR
Intervention: Non-metaphorical meanings
Number of subjects: 20
Study 15159191 — intervention group
Group type: EXPERIMENTAL
Intervention: Verification condition (idiom comprehension test)
Number of subjects: 22
Study 15159191 — intervention group
Group type: EXPERIMENTAL
Intervention: Story condition (idiom comprehension test)
Number of subjects: 22
Study 15159191 — intervention group
Group type: COMPARATOR
Intervention: High and moderate familiarity idioms in verification condition
Number of subjects: 22
Study 15159191 — intervention group
Group type: EXPERIMENTAL
Intervention: Low familiarity idioms in story condition
Number of subjects: 22
Study 11869171 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide (10 mg day-1)
Number of subjects: 12
Study 11869171 — intervention group
Group type: COMPARATOR
Intervention: Acarbose (300 mg day-1)
Number of subjects: 12
Study 9602197 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physical activity and nutrition program with physical activity enrichment for higher risk children
Number of subjects: 800
Study 9602197 — intervention group
Group type: COMPARATOR
Intervention: No program (control schools)
Number of subjects: 800
Study 8041850 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct mail with named address
Number of subjects: 1000
Study 8041850 — intervention group
Group type: COMPARATOR
Intervention: Direct mail with bulk rate postage
Number of subjects: 1000
Study 8041850 — intervention group
Group type: COMPARATOR
Intervention: Direct mail with first class postage
Number of subjects: 1000
Study 2738909 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-gliadin antibodies (AGA) of subclasses IgG1 and IgG3 in coeliac patients
Number of subjects: 0
Study 2738909 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG3 AGA levels in coeliac group
Number of subjects: 0
Study 2738909 — intervention group
Group type: COMPARATOR
Intervention: IgG4 titres in control group
Number of subjects: 0
Study 2738909 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-gliadin-specific complement fixation in coeliac patients
Number of subjects: 0
Study 2738909 — intervention group
Group type: COMPARATOR
Intervention: Alpha-gliadin-specific complement fixation matched for total IgG AGA
Number of subjects: 0
Study 29278929 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg orally (PO)
Number of subjects: 170
Study 29278929 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg PO
Number of subjects: 170
Study 29278929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 28410886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sternoclavicular grafts (SCG)
Number of subjects: 22
Study 28410886 — intervention group
Group type: COMPARATOR
Intervention: Transport distraction osteogenesis (TDO)
Number of subjects: 22
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: abiraterone acetate
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: enzalutamide
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: High subcutaneous adipose tissue (SAT) index
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal muscle mass (SMM) index
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral metastasis
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 120
Study 26278649 — intervention group
Group type: EXPERIMENTAL
Intervention: SAT index
Number of subjects: 120
Study 23642944 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish classical music
Number of subjects: 60
Study 23642944 — intervention group
Group type: COMPARATOR
Intervention: Resting period (control group)
Number of subjects: 60
Study 21565322 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonephelometric assay (INA)
Number of subjects: 0
Study 21565322 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear magnetic resonance (NMR)
Number of subjects: 0
Study 21565322 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-high-density lipoprotein cholesterol
Number of subjects: 0
Study 21565322 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical auto profile (VAP)
Number of subjects: 0
Study 19243778 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 min, one-on-one education and counseling session
Number of subjects: 3522
Study 19243778 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3522
Study 17046320 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-1 shedding
Number of subjects: 22
Study 17046320 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-1 peak viral load
Number of subjects: 22
Study 17046320 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-1 detection
Number of subjects: 22
Study 17046320 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-2 detection
Number of subjects: 22
Study 15744697 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenic Protein-1 (OP-1) with intramedullary rod fixation
Number of subjects: 122
Study 15744697 — intervention group
Group type: COMPARATOR
Intervention: Fresh autogenous bone graft with intramedullary rod fixation
Number of subjects: 122
Study 15744697 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteogenic Protein-1 (OP-1)
Number of subjects: 122
Study 15744697 — intervention group
Group type: COMPARATOR
Intervention: Fresh autogenous bone graft
Number of subjects: 122
Study 11252646 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 6
Study 11252646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 9263186 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 81
Study 9263186 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral group: 20 mg zinc, 100 micrograms selenium
Number of subjects: 81
Study 9263186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin group: 120 mg vitamin C, 6 mg beta‐carotene, 15 mg vitamin E
Number of subjects: 81
Study 9263186 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral and vitamin group: Zn 20 mg, Se 100 micrograms, Vit C 120 mg, beta CA 6 mg, Vit E 15 mg
Number of subjects: 81
Study 8470850 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU admissions
Number of subjects: 16622
Study 6924693 — intervention group
Group type: EXPERIMENTAL
Intervention: Demand feeding (N = 18)
Number of subjects: 36
Study 6924693 — intervention group
Group type: COMPARATOR
Intervention: Scheduled feeding (N = 18)
Number of subjects: 36
Study 31539371 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG)
Number of subjects: 60
Study 31539371 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 60
Study 27931053 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restricted Resistance Exercise (BFR‐RE) at 30% of 1-RM
Number of subjects: 12
Study 27931053 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Exercise (HI‐RE) at 80% of 1-RM
Number of subjects: 12
Study 27931053 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Resistance Exercise (LI‐RE) at 30% of 1-RM
Number of subjects: 12
Study 24961993 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-assisted balance and gait training (BAL)
Number of subjects: 51
Study 24961993 — intervention group
Group type: COMPARATOR
Intervention: Strengthening exercises (CON)
Number of subjects: 51
Study 23376475 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adults (23-25 years old)
Number of subjects: 74
Study 23376475 — intervention group
Group type: COMPARATOR
Intervention: Late adolescents (18-19 years old)
Number of subjects: 74
Study 21548978 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible nasendoscope with gel cap
Number of subjects: 35
Study 21548978 — intervention group
Group type: COMPARATOR
Intervention: Flexible nasendoscope without gel cap (control)
Number of subjects: 35
Study 19399262 — intervention group
Group type: EXPERIMENTAL
Intervention: CCB plus ACEI (group II)
Number of subjects: 87
Study 19399262 — intervention group
Group type: COMPARATOR
Intervention: CCB (group I)
Number of subjects: 87
Study 17708625 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb treatment
Number of subjects: 103
Study 17708625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 16787193 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day) for 7 days
Number of subjects: 0
Study 12672280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment
Number of subjects: 56
Study 12672280 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) assessment
Number of subjects: 56
Study 12672280 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of Daily Living (ADL) assessment
Number of subjects: 56
Study 10448024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 603
Study 10448024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study 7742052 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic somatostatin (4.5 mg daily in continuous perfusion for 7 days postoperatively)
Number of subjects: 35
Study 7742052 — intervention group
Group type: COMPARATOR
Intervention: Control group (no somatostatin)
Number of subjects: 35
Study 2048370 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (E)
Number of subjects: 661
Study 6752929 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamifylline
Number of subjects: 16
Study 6752929 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 16
Study 31657637 — intervention group
Group type: EXPERIMENTAL
Intervention: 750-g ice bag applied for 10 to 60 minutes based on subcutaneous adipose thickness
Number of subjects: 14
Study 28178599 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexpramipexole (50mg to 300mg daily)
Number of subjects: 0
Study 28178599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25367403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cancer recovery (MBCR)
Number of subjects: 88
Study 25367403 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy (SET)
Number of subjects: 88
Study 25367403 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group (MBCR and SET)
Number of subjects: 88
Study 25367403 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control (1-day stress management seminar)
Number of subjects: 88
Study 22692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Force Endurance (FFE)
Number of subjects: 10
Study 22692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum Strength (MAX)
Number of subjects: 10
Study 22692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Endurance (SE)
Number of subjects: 10
Study 22692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophy (HYP)
Number of subjects: 10
Study 22692106 — intervention group
Group type: COMPARATOR
Intervention: All RTMs
Number of subjects: 10
Study 21748907 — intervention group
Group type: EXPERIMENTAL
Intervention: A-50 condition (50% alignment to gravito-inertial force)
Number of subjects: 12
Study 21748907 — intervention group
Group type: COMPARATOR
Intervention: A-0 condition (0% alignment to gravito-inertial force)
Number of subjects: 12
Study 21748907 — intervention group
Group type: COMPARATOR
Intervention: A-100 condition (100% alignment to gravito-inertial force)
Number of subjects: 12
Study 21748907 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 12
Study 18071079 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril, target dose 40 mg/d
Number of subjects: 2553
Study 18071079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2553
Study 16521091 — intervention group
Group type: EXPERIMENTAL
Intervention: MR elastography
Number of subjects: 25
Study 12672922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprinkles containing 80 mg iron and 10 mg zinc (FeZn)
Number of subjects: 304
Study 12672922 — intervention group
Group type: COMPARATOR
Intervention: Sprinkles containing 80 mg iron (Fe)
Number of subjects: 304
Study 12672922 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Fe and FeZn)
Number of subjects: 304
Study 12672922 — intervention group
Group type: EXPERIMENTAL
Intervention: FeZn group
Number of subjects: 304
Study 12672922 — intervention group
Group type: COMPARATOR
Intervention: Fe group
Number of subjects: 304